Toutes les études
RecrutementOBSERVATIONNEL

A Global Prospective Observational Registry of Patients With Pompe Disease

This study is collecting important information from people with Pompe disease across the globe. It's looking at how different treatments, like Cipaglucosidase alfa, Miglustat, Alglucosidase alfa, or Avalglucosidase alfa, affect patients' health and daily lives over a long period. The study also includes people who aren't currently receiving treatment for Pompe disease, to understand how the condition develops naturally. Researchers want to track any side effects from treatments, see how effective they are in the real world, and understand their impact on quality of life. This helps doctors and researchers learn more about Pompe disease and its treatments.

En un coup d'œil

Statut
Recrutement
Sponsor
Amicus Therapeutics
Objectif d'inscription
500
Démarrer
16 févr. 2024
Achèvement estimé
20 Dec 2034

De quoi parle cette étude ?

This study is like a large, ongoing health record for people with Pompe disease. Researchers around the world are carefully watching and collecting information from many patients. The main goal is to understand how the disease progresses over time, both in people who are receiving treatment and in those who aren't currently being treated. This type of study, called an 'observational registry,' means that doctors will continue to treat patients as they normally would, but will also record details about their health and how they are feeling.

The study is particularly interested in a few key areas. Firstly, it wants to track any side effects or serious health problems that might occur with the different treatments for Pompe disease. This helps to make sure treatments are as safe as possible. Secondly, it aims to see how well these treatments actually work in people's everyday lives, not just in controlled trial settings. This includes looking at how treatments affect a person's overall quality of life and their own reports about how they are feeling.

Finally, by including people who aren't yet treated, the registry will help scientists understand the natural course of Pompe disease. This information is very important for developing new treatments and understanding when and how to best manage the condition. By gathering all this information, doctors and researchers hope to improve care for everyone with Pompe disease in the future.

Points clés

  • A global study tracking Pompe disease patients over time.
  • Compares treated and untreated patients to understand disease progression.
  • Aims to learn about treatment safety, effectiveness, and impact on quality of life.
  • Helps improve future care for people with Pompe disease.
  • Involves collecting health information from your regular medical visits.

Qui peut être éligible ?

To join this study, you must have received a clear diagnosis of Pompe disease. This diagnosis needs to be confirmed by specific tests that show either a lack of a certain enzyme (called GAA) or changes in your genes related to GAA.

The study welcomes people with both types of Pompe disease: LOPD (late-onset) and IOPD (infantile-onset).

You cannot join this study if you are already taking part in another study for a new, experimental Pompe disease treatment, or if you're receiving a treatment not widely available through special access programs.

Cet étude pourrait-elle vous convenir ?

Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.

  1. Do I have a confirmed diagnosis of Pompe disease (IOPD or LOPD)?
  2. Has my diagnosis been verified by specific enzyme or gene tests?
  3. Am I currently receiving standard approved treatments or no treatment for Pompe disease?
  4. Am I NOT currently taking part in another study for an experimental Pompe disease treatment?
Répondez à chaque question pour voir votre résultat.

En quoi consiste la participation ?

If you decide to take part in this registry, you won't be given new treatments as part of the study itself. Instead, your doctors will continue to treat your Pompe disease as they normally would. The study involves collecting information about your health over time by reviewing your medical records during your regular doctor's visits. This might include details about your symptoms, any treatments you are receiving (like Cipaglucosidase alfa, Miglustat, Alglucosidase alfa, or Avalglucosidase alfa), any side effects you experience, and how the disease affects your daily life. The duration of your participation will depend on how long the registry continues and how long your doctor feels it is important to track your information.

Risques et avantages potentiels

A potential benefit of joining this study is that it helps doctors and researchers learn more about Pompe disease and its treatments, which could improve care for you and others in the future. As an observational study, there are no new medications or procedures, so the risks are generally low, primarily related to sharing your medical information (which will be kept confidential). You have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (41)

  • University of Arkansas Medical Science
    Code postal vérifié
    Little Rock, États-Unis· Recrutement
  • University of California Irvine
    Code postal vérifié
    Irvine, United States· Recrutement
  • Wolfson Children's Hospital
    Code postal vérifié
    Jacksonville, États-Unis· Recrutement
  • Emory University
    Code postal vérifié
    Atlanta, États-Unis· Recrutement
  • Indiana University, IU Health Physicians Neurology
    Code postal vérifié
    Indianapolis, États-Unis· Recrutement
  • Washington University School of Medicine
    Code postal vérifié
    Saint Louis, États-Unis· Recrutement
  • NYU Neurogenetics, NYU Langone Medical Center
    Code postal vérifié
    New York, États-Unis· Recrutement
  • Centre Médical de l'Université Duke
    Code postal vérifié
    Durham, États-Unis· Recrutement
  • University of Cincinnati Medical Center
    Code postal vérifié
    Cincinnati, United States· Recrutement
  • Cincinnati Children's Hospital
    Code postal vérifié
    Cincinnati, United States· Recrutement
  • University of Pennsylvania Perelman Center for Advanced Medicine
    Code postal vérifié
    Philadelphie, États-Unis· Recrutement
  • University of Pittsburgh
    Code postal vérifié
    Pittsburgh, United States· Recrutement

Questions fréquentes

What is Pompe disease?

Pompe disease is a rare genetic condition where the body can't properly break down a complex sugar, leading to muscle weakness and other problems.

Will I get a new treatment if I join this study?

No, this study doesn't provide new treatments. You will continue to receive the standard care for your Pompe disease from your doctor.

What does 'observational' mean?

It means doctors will simply observe and record information about your health and how your disease progresses during your regular medical appointments.

Who can participate in this study?

Anyone with a confirmed diagnosis of Pompe disease, either late-onset (LOPD) or infantile-onset (IOPD), can potentially join.

Will my information be kept private?

Yes, all the information collected about you will be handled with strict confidentiality and your identity will be protected.

Comment en savoir plus

For Site

Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.

Intéressé à participer ?

Inscrivez votre intérêt

Partagez vos coordonnées et l'équipe de recherche pour "A Global Prospective Observational Registry of Patients With… vous contactera si vous êtes éligible. Consultez toujours votre médecin avant d'accepter de participer.

Discussion

Discussion communautaire

Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.